Professor, Medical University of Lublin, Poland, E-mail: [email protected]
The global antibiotics market was valued at USD 42,653.89 million in 2018 and is estimated to be valued at USD 56,369.92 million in 2024, witnessing a CAGR of 4.7%. Certain factors that are driving the market growth include the emergence of anti-MRSA drugs, development of generic drugs, and vulnerable aging population. This can be mainly associated with the growing incidences of infectious diseases such as pneumonia, HIV/AIDS, malaria, and tuberculosis along with technological advancements that are expected to become the most common growth factors globally in the coming years.
The global DNA sequencing market is projected to reach USD 85.5 Million by 2025 from USD 310.1 Million in 2017 growing at a CAGR of 8.5% during the forecast period.
The global market for food antibiotics reached nearly $7.1 billion in 2017. This market is expected to grow to nearly $9.6 billion in 2017 and $15.7 billion by 2025, with a Compound Annual Growth Rate (CAGR) of 8.1% from 2017 to 2025.
Global nanotechnology market was valued at $216.2 billion in 2017 and $448.3 billion in 2017. The total market is projected to grow at a Compound Annual Growth Rate (CAGR) of 19.3% from 2017 through 2025 and reach $828 billion by 2025.
Hilaris Conferences on Antibiotics: Discovery & Development 2020 is the world stage for presenting researches with reference to antibiotics, infections and exchanging ideas, contributes to the dissemination of information in Antibiotics & Antimicrobials for the advantage for both the academic and business.
• Food Safety Experts
• Alliances of antibiotics
• Business Entrepreneurs
• Antibiotics Researchers
• Strategic Drug Development
• Executive Council of Global
• Directors of Pharma Industries
• Medical Affairs and Networking
• Public Health Preparedness Sectors
• Scientific Business Communications
• Antibiotics Associations & Societies
• Associate Professors
• Medical companies
• Pharmaceutical companies